• Font Size
  A A A
• |
• Workforce Health
• |
• Physicians
• |
• Contact Us

Heart and Vascular

• CHAMPION PCI
  Acute Coronary Syndrome   ( Undergoing PCI )
  
  This Phase III clinical trial is evaluating cangrelor, a fast-acting, reversible, intravenous (IV) antiplatelet agent for preventing platelet activation and aggregation during the clotting process, in patients undergoing coronary procedures ( e.g. PCI ).

• PFO ACCESS Registry
  (Stroke patients with presumed embolism through a PFO)
  
  The primary objective of the PFO ACCESS Registry is to allow access to the APLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes fue to presumed paradoxical embolism through a patent foramen ovale (PFO) and who have failed conventional drug therapy.

• Visipaque
  ( Patients with Unknown Coronary Artery Disease undergoing Coronary CTA )
  
  This is a Phase IV registry study for patients with chest pain syndrome and an intermediate pre-test probability of CAD undergoing coronary computed tomography angiography (CCTA) examination as part of a routine work up. This study is being conducted to compare the CCTA scan (CT scan of the heart) results with any heart related problems the patient may have 1-month, 6-months and 12-months after the scan.